chr15-51766481-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014548.4(TMOD2):āc.40A>Gā(p.Asn14Asp) variant causes a missense change. The variant allele was found at a frequency of 0.0000235 in 1,614,122 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00016 ( 0 hom., cov: 33)
Exomes š: 0.0000089 ( 0 hom. )
Consequence
TMOD2
NM_014548.4 missense
NM_014548.4 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 4.26
Genes affected
TMOD2 (HGNC:11872): (tropomodulin 2) This gene encodes a neuronal-specific member of the tropomodulin family of actin-regulatory proteins. The encoded protein caps the pointed end of actin filaments preventing both elongation and depolymerization. The capping activity of this protein is dependent on its association with tropomyosin. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.018782109).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMOD2 | NM_014548.4 | c.40A>G | p.Asn14Asp | missense_variant | 2/10 | ENST00000249700.9 | NP_055363.1 | |
TMOD2 | NM_001142885.2 | c.40A>G | p.Asn14Asp | missense_variant | 2/9 | NP_001136357.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMOD2 | ENST00000249700.9 | c.40A>G | p.Asn14Asp | missense_variant | 2/10 | 1 | NM_014548.4 | ENSP00000249700 | P1 | |
TMOD2 | ENST00000435126.6 | c.40A>G | p.Asn14Asp | missense_variant | 2/9 | 2 | ENSP00000404590 | |||
TMOD2 | ENST00000539962.6 | c.-175A>G | 5_prime_UTR_variant | 2/11 | 2 | ENSP00000437743 | ||||
TMOD2 | ENST00000560576.1 | n.207A>G | non_coding_transcript_exon_variant | 2/3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152242Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
25
AN:
152242
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251336Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135840
GnomAD3 exomes
AF:
AC:
3
AN:
251336
Hom.:
AF XY:
AC XY:
1
AN XY:
135840
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461762Hom.: 0 Cov.: 30 AF XY: 0.00000825 AC XY: 6AN XY: 727180
GnomAD4 exome
AF:
AC:
13
AN:
1461762
Hom.:
Cov.:
30
AF XY:
AC XY:
6
AN XY:
727180
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000164 AC: 25AN: 152360Hom.: 0 Cov.: 33 AF XY: 0.000201 AC XY: 15AN XY: 74498
GnomAD4 genome
AF:
AC:
25
AN:
152360
Hom.:
Cov.:
33
AF XY:
AC XY:
15
AN XY:
74498
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2021 | The c.40A>G (p.N14D) alteration is located in exon 2 (coding exon 1) of the TMOD2 gene. This alteration results from a A to G substitution at nucleotide position 40, causing the asparagine (N) at amino acid position 14 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;B
Vest4
MutPred
Loss of methylation at K13 (P = 0.0726);Loss of methylation at K13 (P = 0.0726);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at